Please cite our paper: Bhyravbhatla N*, Alsafwani ZW*, Thapa I, et al. Targeting Oncomucin-driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer. Gastroenterology. Published online May 25, 2026. doi:10.1053/j.gastro.2026.04.041
-
Updated
Jul 9, 2026 - HTML